Medications

FDA lifts hold on experimental Ebola drug

Federal health authorities have eased safety restrictions on an experimental drug to treat Ebola, a move that could clear the way for its use against an unprecedented outbreak of the deadly virus in West Africa.

Aug 07, 2014
popularity not rated yet | comments 0

Dimethyl fumarate for MS: Added benefit is not proven

Dimethyl fumarate (trade name: Tecfidera) has been approved since January 2014 for adults with relapsing remitting multiple sclerosis (RRMS). In an early benefit assessment pursuant to the Act on the Reform of the Market ...

Aug 07, 2014
popularity not rated yet | comments 0

Ethical issue: Who gets experimental Ebola drug?

The use of an experimental drug to treat two Americans diagnosed with Ebola is raising ethical questions about who gets first access to unproven new therapies for the deadly disease. But some health experts ...

Aug 06, 2014
popularity not rated yet | comments 0

Safety concerns about new drugs revealed

What's safer: a newly approved drug or one that has been on the market much longer? Newer drugs have a one in three chance of acquiring a black box warning or being withdrawn for safety reasons within 25 years of their approval, ...

Aug 04, 2014
popularity 5 / 5 (1) | comments 0